Charles River Laboratories International, Inc. · NYSE:CRL
Coleman Glenn bought 10 Charles River Laboratories International, Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Coleman Glenn (EVP & Chief Financial Officer) bought 10 Charles River Laboratories International, Inc. shares at US$297.43 for US$2,974, leaving 27,762 shares. Filed Oct 2, 2026 (Form 4).
- Bought
- 10 shares
- Price
- US$297.43
- Value
- US$2,974
- Holding after
- 27,762 shares
- Trading plan
- No
- Role
- EVP & Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Buy | 10 | US$297.43 | 27,762 | Direct |
Source
Related
- Charles River Laboratories International, Inc.
- Coleman Glenn
- Charles River Laboratories International, Inc. shareholders
- Form 4 · Coleman Glenn · Jun 2, 2026
- Form 4 · Coleman Glenn · May 4, 2026
- Form 4 · Parisotto Shannon M · Oct 7, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Form 4 · Foster James C · Aug 27, 2026
- Form 4 · Girshick Birgit · Aug 20, 2026
- Form 4 · Parisotto Shannon M · Aug 20, 2026